Rothschild Capital Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-39,700	Closed	-$2.01M	–	57
2016 Q3	$2.01M	Buy	+39,700	New	+$2.01M	0.72%	36